ClinicalTrials.Veeva

Menu

Covid-19 at the Regional Medical Center Metz-Thionville: a Descriptive Study (COMETE-19)

C

Centre Hospitalier Régional Metz-Thionville

Status

Completed

Conditions

COVID

Study type

Observational

Funder types

Other

Identifiers

NCT04430322
2020-02Obs-CHRMT

Details and patient eligibility

About

France and especially the region "Grand Est" have been damaged by the COVID-19 pandemic. This pandemic resulted in a reorganization of the hospitalization sectors.

In order to better understand the disease, the investigators wish to carry out a descriptive analysis of hospitalized patient data. This study would notably allow us to identify some prognostic factors.

The main objective of this study is to identify individual factors that are associated with a poor prognosis (with ICU admission or death).

Enrollment

1,045 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient hospitalized in COVID Unit at the Regional Hospital Center Metz-Thionville during the COVID 19 pandemic
  • PCR positive or COVID confirmed with clinical evidence and CT scan

Exclusion criteria

  • Patients not willing to participate via using their medical files
  • Patient transferred after a brief stay in another hospital

Trial contacts and locations

1

Loading...

Central trial contact

Vincent DINOT; Rostane GACI, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems